Math3uS1872 | Matheus BD Connections, LLC

July Networking Summary

The GLSA | FOCM Networking Event on Wednesday, July 20th, 2022 at 5:00 PM EST was a lively affair boasting a diverse crowd of life science professionals. Many who attended were the previous colleagues and / or the current friends of Chris Matheus (FOCM, President; GLSA Chief Commercial and Networking Officer).

The topic of the day was “Summer Fun” due to the prevalence of the industry to go semi-dormant in July and August to accommodate the well-deserved vacations of its workers. The introduction, led by Chris, briefly spoke of former events which usually involved the related capabilities or education topic of a guest speaker to spur industry-related discussions and aid in collaboration among the group. He expressed the intention of this event to be focused more on the personal activities and vacations of attendees in order to keep our minds on the relaxation of these summer months.

To nobody’s surprise, we couldn’t stay away from discussing work including the most recently held conferences; BIO International Convention in San Diego, CA and DIA Annual Meeting in Chicago, IL with a specific mention about the limited presence of sponsors. An outbreak of Coronavirus at these events and the apparently foul-tasting Paxlovid medicine used to treat moderate cases of COVID sparked conversation about who among us has contracted the virus and the varying degrees by which each individual was affected.

Andrew Mulchinski stated that Symbio hasn’t fully adapted to DCT yet, sparking the post-quarantine observations of many regarding the transition to decentralized and hybrid studies. Chris noted a number of CRO’s that have changed leadership or have been acquired by other companies.

By far the most celebratory moment of the event was the announcement of the recent success of the Memorial Sloan Kettering Cancer Center in a small clinical trial using immunotherapy. They achieved 100% remission of rectal cancer without the use of surgery, chemotherapy or radiation that can leave patients with life-long effects including infertility and colostomy bags.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present briefly on an educational life sciences topic and spur our event discussions, please contact me.

Attendees: (first time attendees in bold)

Kimberly Lupo, MS, MBA, RAC	Founder & CEO at Portrett Pharmaceuticals LLC
Sara Tylosky	CEO, Farmacon
Nadia M. Bracken	Operational Advisor, Medidata
Brian Horan	CEO & Co-founder, SupplyRx
Tina Tran	Director, Business Development, Unlearn.ai
Heather Hollick	Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Amy Zastawney	Seeking a new executive business development role
Jon Matheus	Commercial Real Estate, A.T. Pancrazi Real Estate Services
Unnat Patel	Founder & President, AnalysisMate
Peter Payne	Life Sciences Executive – Available for Consulting
Griffin Robertson	Partner Account Manager, Mednet
Nancy Zeleniak	Enterprise Strategic Partnerships & Participant Engagement; Atrium Health
Dhruv Wadhwa	Director of Business Development, HUMA
Michael Young	Founder & Principal, BIOMedworx
Scott Robertson	Vice President of Sales, Global Partnerships; Mednet
Ravipal Luthra, MS, BDS	Clinical Research Coordinator, University of Miami, Miller Medical Center
Andrew Mulchinski, MPA, MT, ASCP, CCRC	Business Development; Symbio, LLC
Lani Hashimoto	Associate Director Patient Engagement Management; Novartis
Amanda Putnam	Team Lead Manager; Data Recognition Corporation
Michael O’ Gorman	CEO and Founder at Life Science Marketplace
Eliana Burke	Global Head of Client Engagement & Marketing; Greenlight Clinical
Michael Minor	EVP, Clinical Research; IMA Clinical Research
Vaibhav Sawant	Pharma Marketing Executive
GLSA ATTENDEES
Denise McNerney	Chief Operations Officer
Hannah Lloyd	Account Manager
Zulma Varela	Director of Public Communications
Sally Haller	Operations Manager
Todd Neilson	Account Manager
Joe Buser	Chief Revenue Officer
Chris Matheus	Chief Commercial and Networking Officer
Yutong Liang	Intern, Data Management and Technology

Screen shots of the event follow:

May Networking Event Summary

On May 18, the GLSA and FOCM held their monthly online networking event. We always start the meeting with some time for people to give an update on any news they’re heard or a significant event that has happened in the past month. Then we move to a featured presenter for 10 – 15 minutes presenting information about themselves, their company or a clinical research topic of relevance to them or to the industry.

This event featured Alison Macpherson, CEO and Founder of Bright Pharmaeutical Services, a full service CRO headquartered in Los Angeles. Bright is celebrating their 20th year in business.
http://www.brightps.com/

Alison talked about her experiences starting out in the clinical trials industry and how that led to her forming Bright with a boutique sponsor-centric approach and a focus on subject recruitment and retention. The company has worked in a variety of therapeutic areas and all phases of research. Its differentiators from other similar sized CRO’s is the very low turnover (less than 5%) over the 20 years in business, which means clients’ projects are supported by only very experienced and engaged staff. Additionally, while much of their experience is in phase I and II North America trials, they have worked in 30+ countries globally. Questions were handled as they came up leading to discussions about Bright’s experience with risk-based monitoring; the new normal of hybrid and decentralized trials; reducing the frequency of subject visits to the sites; and Bright’s experience with trials that require collecting data from wireless, connected devices, e-source data, etc.

After the presentation we had first time participants share their company names and experience. Josh Lang, Mike O’Gorman and Denise McNerney will be attending BIO in San Diego June 13 – 16. Carlos mentioned the networking event they are having on June 12 in San Diego for people interested in Farmacon Global’s August 25 conference focused on conducting clinical trials in Rare Diseases in Emerging Markets.In posing this question to the group – what are you working on and what do you need help with, Heather Hollick (who taught me this approach for successful networking) mentioned she is starting the Institute for Vibrant Leadership and could use connections to leaders, coaches with whom to collaborate as well as writers and virtual assistants. Subsequently, a few potential connection candidates have been sent to her. https://heatherhollick.com/

Attendees (bolded names indicate first time attendees):

Alison Macpherson, Bright Pharma Services
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Nicole O’Brien, Pain Care Labs
Josh Lang, Asymchem Group
Barbara Hilewsky, BRCR Global
Shane Krauss, Strados Labs
Carlos Martinez, Farmacon Global
David Holland, Cmed Research
Michael O’Gorman, Life Science Marketplace
Keisha Felix, IQVIA
Ludmilla Scodeler
Jim Choi, CRScube
Cesar Serapiao
Chris Matheus, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Todd Neilson, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance

Several screen shots follow:

April Networking Event Summary

On April 20, the GLSA and FOCM held their monthly online networking event. We always start the meeting with a featured presenter spending 10 – 15 minutes presenting information about themselves and a clinical research topic of relevance to them or to the industry.

This event featured Amy Baxter, MD; CEO and Founder of Pain Care Labs. PCL’s NIH-funded pain relief device is an ingenious intervention to reduce needle pain and fear. https://paincarelabs.com/

Amy presented information on research results showing the incidence of needle fear among Americans. Research shows that 25% of Americans are adverse to needles. This is playing a role in the slower than desired vaccination rates against COVID-19.

Needle fear has increased dramatically since 1995 when it was reported that 10% of adults and 25% of children feared needles. Prior to 1980, children’s last vaccination was at age 2, except for DPT boosters every 10 years. Since 1980, children receive booster injections between the ages of 4 and 6, when fears form. A study in 2012 from Canada shows 63% of people born after 2012 have needle phobia.

Pain Care Labs has developed Buzzy for the management of needle phobia. This combines the distraction of cold with deep vibration which blocks the pain signal. Managing needle phobia is important for increasing vaccination rates among people of all ages. It can also play a role in clinical research if a clinical trial is a vaccine trial or a protocol requiring multiple needle-sticks, Such trials may have higher drop-out rates or decline to enroll due to the subjects’ fear.

After the presentation, there were questions, answers and discussions. We then allowed newer participants the opportunity to tell us about their history in the industry and ask how the group can be of help. Additionally, after the event Heather Hollick shared observations about what makes the GLSA online networking events work so well is:

Starting with initial casual conversation
Having a 15-20 minute learning session
Breaking into groups of 2-4 people several times so all can meet each other and share what they’re working on
Ending with closing remarks, comments and observations.
Online networking requires light moderation, because we’re missing body language for our cue as to who is to speak next.

Amy provided a good suggestion that we start these with a general ice breaker, a question or topic each can respond to. We’ll begin implementing that for our July event. The July and August events will be light-hearted and casual, imagine sipping a cocktail on a beachside outdoor deck with friends. In September, we’ll return to focused topics/presentations after the general ice breaker and before break out networking.

Attendees (bolded names indicate first time attendees):
Amy Baxter, MD; Pain Care Labs
Nicole O’Brien; Pain Care Labs
Peter Payne; Consultant
David Rodrin; IMA Clinical Research
Daniel Paszterko; Myonex
Ari Cofini; VeriSIM Life
Neil Banerjee; QMS Integrity
Nancy Zeleniak; Atrium Health
Mike Minor; IMA Clinical Research
Brittany Barber, Syneos Health
Nicole Aubrey; Aubrey Cole Consulting
Maria Frane, Simbec-Orion
Ravipal Luthra, University of Miami, Miller School of Medicine
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike O’Gorman, Life Science Marketplace
Edwin Gershom, Noble Life Sciences
Hannah Lloyd, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Screenshots from the event:

Amy Baxter, MD; CEO and Founder of Pain Care Labs

Screen shot of Attendees with Teddy in the middle square

March Networking Event Digest

On March 16, the GLSA and FOCM held their monthly online networking event. We start the meeting with a featured presenter spending 10 – 15 minutes presenting information about themselves and a clinical research topic of relevance to them.

This event featured Wessam Sonbol, founder of Delve Health. Wessam has been in the clinical research industry for 23 years. Many of these years have been in leadership and founding roles in the technology and product development sectors to facilitate trials. He founded Delve Health in 2018. Delve Health provides innovative decentralized clinical trial solutions to improve clinical trial conduct for patients, caregivers, doctors and pharma/device. Offerings include ePRO/eCOA, eConsent, study tasks, wearables and biosensor integration, EMR data collection and Real-world evidence capabilities.

After the presentation, there were questions, answers and discussions. We then allowed newer participants the opportunity to tell us about their history in the industry and the group can be of help.

Attendees (bolded names indicate first time attendees):
Wessam Sonbol, Delve Health
Andrew Mulchinski, Symbio Research
Ravipal Luthra, University of Miami, Miller School of Medicine
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Michael Young, biomedwoRx: Life Sciences Consulting
Mike O’Gorman, Life Science Marketplace
Edwin Gershom, Noble Life Sciences
Taylor Biche, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Todd Neilson, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

https://globallifesciencesalliance.com/

Please join us on April 20 where the featured presenter will be Amy Baxter, MD; CEO and Founder of Pain Care Labs. PCL’s NIH-funded pain relief device is an ingenious intervention to reduce needle pain and fear – improving patient participation in clinical trials.

Selected screen shots appear below:

Screenshot with GLSA Mascot Teddy in lower left corner

February Networking Event

On February 16, 2022, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was the second event of 2022 and like the January event, we again had 3 first-time attendees. Thank you to super-connector and FOCM member, Nadia Bracken for sharing our event with others.

We spent the first 15 minutes with introductions and general discussion about the weather in various attendees’ cities.

This event featured a presentation by Kalyan Ghosh, Founder and CEO of Inference, Inc (https://inferenceinc.com/). Inference, a GLSA client, was formed in 2017 by Kalyan. He has over 25 years experience in clinical biostatistics, having worked at both big pharma (Merck and BMS) and CROs (Vislation, INC Research and West Coast Clinical Trials). Kalyan is an accomplished presenter and presented an overview of biostatistics and the role that data management and biostatistics have in drug development.

Please join us next month on March 16 at 7:00 p.m. Wessam Sonbol, CEO of Delve Health, an e-clinical technology platform service provider and client of GLSA will spend 10 – 15 minutes talking about their approach to patient-centered hybrid and decentralized studies in drug development.

ATTENDEES (bolded names were first time attendees):

Kalyan Ghosh, Inference Inc,
Andy Mulchinski, Symbio
Justin Gundelach, Mayo Clinic
Pauline Luong, Creative Clinical R & D
Chris Bergey, NaviDx
Brian Langin, Matrix Medical
Ravipal Luthra, University of Miami College of Medicine
Jon Matheus, A.T. Pancrazi Real Estate Services, Inc.
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Todd Nielson, Global Life Sciences Alliance

Screenshots of the attendees can be seen here:

https://globallifesciencesalliance.com/february-networking-meeting-summary/

Networking Meeting Summary

On January 19, 2022, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was the first event of the new year and we had 3 first-time attendees.

We kept everyone in one main room and went around the room having each person introduce themselves. There was an open dialog and discussion on a variety of topics: expectations for COVID cases and treatments, the impact on travel and conventions/conferences and hopes for it to lessen and burn out and become similar to seasonal flu. The concern for another variant that could put us into strict measures is real yet the thought of having to deal with that makes us tired.

Heal Mary, (https://healmaryapp.com/) a GLSA client is an oncology patient recruitment platform founded by Cassandra Hui. Cass is from the tech industry and she started Heal Mary driven by her personal story: “My mom was told to go home and get her affairs in order, that there were no other options… I’ve made it my mission to ensure that patients know ALL of their options.” We showed a video of Cass explaining the motivation for starting Heal Mary using her tech and Artificial Intelligence skills to make sure patients know of treatment options available via clinical trials. https://www.youtube.com/channel/UCLB_CmGY3-trX3rKePF0FWw

Please join us next month on February 16. Kalyan Ghosh of Inference, a data management and biostatistics service provider and client of GLSA will spend 10 minutes talking about the role of data management and biostatistics in drug development.

ATTENDEES (bolded names were first time attendees):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates
Kate Findlen, Life Molecular Imaging
Kimberly Lupo, Portrett Pharmaceuticals
Mike O’Gorman, Life Science Marketplace
Andy Mulchinski, Symbio
Brian Langin, Matrix Medical
Charlie Speno, Matrix Medical
Michael W. Young, biomedwoRx: Life Sciences Consulting
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance

Screenshots of the event follow:

Networking Event Summary

On December 15, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was our year-end event and we didn’t have a speaker or theme.

We kept everyone in one room and went around the room asking people to answer a variety of questions. We asked for each person to share what positive or memorable thing happened in 2021 and what they were looking forward to happening in 2022.

A representative answer was that while some had caught COVID and it was a bad illness, no one had anyone in their families get severely ill or pass away from it. The outlook for 2022 was felt to be somewhat tentative with the global rise of infections due to the Omicron variant. It was noted that the annual January JP Morgan conference will be virtual again due to the rise in cases. (Occurring today, December 22, Pfizer’s oral dose anti-viral pill to treat COVID was approved.)
Michael Young shared that 2021 found him becoming a grandfather with the birth of grandson Oliver Kiesing Miller (pictures below attendee listing). Michael’s hopes for 2022 include completing the first draft of a book he’s writing on “Branding”. He also echoed the feelings of many of us – having the opportunity to see clients, customers and friends in person and a return to in-person conferences. (I think this is the equivalent of a blood transfusion for extroverts).

Ires Alliston shared that she is hosting a Female Expert Coaches Summit May 9 – 11 in Daytona Beach, FL. More information is available here: (https://femceosummit.com/).

Movies/TV shows people are watching/recommending:

You
The Unforgiveable
Get Back
Curb Your Enthusiasm
Giri/Haji
Yellowstone

Fountain pens

It turns out that Nadia Bracken has found the hobby of collecting fountain pens. Someone else on the call mentioned a former boss who also did so. There was a discussion about the psychological draw toward collecting such pens. I subsequently found this discussion group (https://www.fountainpennetwork.com/forum/topic/136590-pen-personality/) .The hobby appears to be more associated with introversion based on the non-controlled survey in the discussion group. Another article on the topic is: https://www.inkedhappiness.com/fountain-pen-collecting-the-psychology-behind-my-madness/

Toward the end of the event, two things occurred after some had dropped off:

Dan Weddle sang and played his guitar
Michael Young arrived and showed pictures of his adorable 1^st grandson

Please join us next month on January 19.

ATTENDEES (bolded names were first time attendees):

Kevin Boos, Rho
Brian Horan, SupplyRx
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Ires Alliston, Business Coach, Consulting & Marketing
Chris Bergey, Humphries Insurance Agency
Nadia Bracken, Medidata
Dan Weddle, AltaSciences
Mike O’Gorman, Life Science Marketplace
Patrick Champoux, SkillPad
Maria Frane, Simibec-Orion
Sara Tylosky, Farmacon
Brennan Munley, Rho
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Photo Collection

Illustrious Clinical Research Industry Professionals

Denise, Zulma and Michael concluding the meeting

Michael Young’s grandson Oliver Kiesing Miller

November Networking Event Summary

One of the things I thoroughly enjoy about networking is meeting such interesting, fascinating people with different perspectives. This helps us understand and appreciate those differences and helps us re-consider our approach to certain things.

On November 17, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event.

Whereas last month we had a featured speaker – Heather Hollick on LinkedIn best practices; this time we just had general discussion and greeting of one another. While there were still a manageable number, I introduced each person and how I know them. There was also discussion and general agreement that when Merck and Pfizer get their oral dose antiviral medicines approved (whether emergency authorization or full approval); the COVID-19 pandemic will become very manageable and the world can return to our new normal; forever impacted but less restricted. (added since the 11/17 meeting – the identification of the Omicron variant may put a slow down on the return; however, early information indicates that while it’s easily transmissible, the symptoms are different and mild, such that as of Nov 30 in South Africa hospital where the doctor found the Omicron variant, no hospitalizations are attributed to it. And now just today, an FDA Advisory panel recommended approval for Merck’s anti-viral pill to treat COVID-19 and reducing hospitalizations.)

We then moved to the evening’s agenda. We had three rooms for people to go to depending on their interests. The three discussion topics were:

Clinical Trial Recruitment and Retention
Innovation and Technology
Networking

Heather Hollick chaired the Networking room. One discussion centered around how sales/business development people use it and consultant/subject matter experts use it to best fill their connection needs. Interestingly, several participants shared that they control their LinkedIn outreach and purposefully limit their contacts to a more easily managed subset (~1000) to maximize the depth of relationships. Several other participants use a more liberal approach and have grown their networks to over 10,000 contacts who then serve as “private wikis” allowing rapid access to large groups of professionals with multivarious experiences.

Please join us next month on December 15 and if you have a Christmas sweater – wear it!

ATTENDEES (bolded names were first time attendees, I think):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates, LLC
Lacey Clements, IMA Clinical Research
Kevin Boos, Rho
Valerie Roussin-Paradis, SkillPad
Edwin Gershom, Noble Life Sciences
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Nicole Yoon, Mediaiplus
Ires Alliston, Business Coach, Consulting & Marketing
Lindsey Summers, Green Key Resources
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Brandon Huffman, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

https://globallifesciencesalliance.com/news/

CNS Summit Conference 2021

The CNS Summit, a year-round community with an annual in-person Summit was held at the Encore Resort Boston Harbor. It was very well-attended with over nine hundred registered. There was a feeling of pent-up need for networking and reconnecting. It is quite apparent that participants at this meeting are enthusiastic to be attending in person. The joy and happiness of seeing friends, colleagues (past and current) and being able to freely move about and make new connections was palpable. There is such a willingness to hear about what each other is up to, has learned and is doing different since the last time we gathered in person.

Rapid antigen testing was conducted rapidly for Covid-19, and a negative test result (within about 15 minutes) indicated by a wristband provided, allowing access to the Summit. The testing was provided by CNS Summit in partnership with Care Access. The process went off flawlessly, a great testament to the Care Access and CNS Summit staff involved.

There were many exhibitors, patrons and sponsors. To see which companies participated, I recommend you go to the website: https://cnssummit.org/

Digital Biomarkers, Artificial Intelligence, Machine Learning, Big Data, Patient Diversity, Real World Data were among many Spotlight topics. As an example, Sharecare and UCB presented real-world data on patients with Myasthenia Gravis. The insights learned, the new endpoints discovered and the capabilities of the smartphone in such trials was impressive.

Below is the expanding list of companies that define themselves as DCT clinical trial service providers. Go to https://www.dtra.org/ Decentralized Trials & Research Alliance to fully appreciate the expansion of companies and organizations in and/or getting into the decentralized research segment of our industry.

Curebase	Circuit Clinical
Medable	Science 37
TrialBee	Thread
CaptureProof	Care Access
Clinical Ink	DataCubed Health
Medocity	Medidata
ShareCare (SmartOmix)	Science 37
	SiteRx

If you are interested in the CNS Summit community and the opportunity for interacting within it year round, you can apply at the organization website, which is listed above in paragraph 3.

And on a sad note, Medidata co-founder, Glenn DeVries who attended and presented at the conference passed away November 11 in a private plane crash in New Jersey.

Technology changes so quickly

Maybe the title of this should be “the pace of change”. Recently while starting a company with people much younger than me, I felt like I had missed several years of involvement in the world.

With the accelerating pace of technological change, many of us find ourselves behind in keeping up with new software, programs, and technological processes implemented in the workplace.

A critical part of adapting to the digital advancements is learning and training. Implementing various types of training systems, such as written instructions and live video training to accommodate different work styles and preferences may be helpful.
In order to be effective, we need to identify the technological changes that will enable us to attain the goals of our future projects and avoid those that could jeopardize their completion.

How can we adapt to the rapid, sometimes unpredictable digital advancements? How do we prepare ourselves for the new technology processes? How do you know if you indirectly resist the changes and how can you solve that?

The Uncertainty about future or current technologies might have nothing to do with the technology itself, but instead with how we respond to the changes.

I don’t know if kids still read Washington Irving’s story of Rip Van Winkle. https://en.wikipedia.org/wiki/Rip_Van_Winkle It’s about a man who fell asleep and woke up 20 years later and it was hard to accept all that had changed. Well, lately, I feel like I’ve been asleep for 10 years and have completely missed some of the digital advances and even the more mundane.

Let’s address the mundane one first, so tonight I stop in at Staples because I’m all out of “business” envelopes – you know the type, the long envelope that if you wanted to mail an 8.5 x 11 inch letter to someone, you’d fold it in thirds-ish and put it in this envelope. So I confidently stride to the aisle labeled Envelopes and begin looking for business envelopes. No such thing to be found. They had boxes of an envelope with the wording Number 10. So I look at the dimensions and it seems that they would work. At check out, to confirm I was buying what I needed, I ask the two 20-30 year olds – one was a manager – at check out, “are these envelopes the same as what I know as “business envelopes”? They, of course, had never heard that term. So I explained that I was looking for what I know as business envelopes, they said, well, yeah it looks like that would fit as this is 9 and a half inches wide.

Now to the digital world – so a client of ours texts us to say he’ll be texting us an image that we’re to take a picture of and save for later use in demo’ing his product at a conference. Those simple 6 words: “take a picture of and save”. So that I know what I’m to do I reply with: “just to confirm – by take a picture of and save – do you mean that I’m to use my iPhone and when I see the image I’m to do that iphone thing where I push a button on the side of the phone and at the same time push the round home button such that it takes a screen shot and then once that’s done I click on the screen shot and select “save to pictures”? He replied, “yes”. So you see what’s happening here? 59 words of explanation are needed for me to understand, interpret and act on his 6 words.

You should pray for my colleagues, this type of thing happens nearly weekly. You should pray for my colleagues, this type of thing happens nearly weekly. Quite simple really isn’t it: “take a picture and save it.” *%$”(#*%4”@$(*$*(#@$*(@#)